Journal of Critical Care
Volume 25, Issue 2 , Pages 214-220, June 2010

Overuse of stress ulcer prophylaxis in the critical care setting and beyond

  • Christopher P. Farrell, DO

      Affiliations

    • Department of Internal Medicine Residency Program, Annenberg Conference Center, Lankenau Hospital, Wynnewood, PA 19096, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 215 850 2575; fax: +1 610 645 8141.
  • ,
  • Giancarlo Mercogliano, MD

      Affiliations

    • Division of Gastrointestinal Medicine, Lankenau Hospital, Wynnewood, PA 19096, USA
  • ,
  • Catherine L. Kuntz, MD, MS

      Affiliations

    • Department of Internal Medicine Residency Program, Annenberg Conference Center, Lankenau Hospital, Wynnewood, PA 19096, USA
    • Division of Pulmonary and Critical Care Medicine, Lankenau Hospital, Wynnewood, PA 19096, USA

published online 17 August 2009.

Abstract 

Background

Patients admitted to the intensive care unit (ICU) are susceptible to stress ulcers. We hypothesize that despite recommendations, stress ulcer prophylaxis (SUP) is still overused in the ICU and often continued after resolution of risk factors for bleeding.

Methods

We retrospectively studied all ICU admissions for 4 months. Risk factors for stress ulcer bleeding were collected. Patients were categorized into 4 groups: (1) ≥1 major risk factor; (2) ≥1 minor risk factors; (3) no risk factors; (4) preadmission use of acid-suppressive medication. The rate of SUP was calculated by group during ICU stay, on transfer from the ICU, and at hospital discharge.

Results

Two hundred ten patients were studied. Of all the ICU admissions, 87.1% received SUP. Among patients with no risk factors, 68.1% were placed on prophylaxis on ICU admission; 60.4% continued on treatment upon transfer from the ICU; 31.0% were discharged home on an agent without a new indication.

Conclusions

Although judicious use of SUP in high-risk patients can decrease the incidence of gastrointestinal bleeding, inappropriate use may increase drug reactions, unnecessary hospital costs, and personal monetary burden. Our findings argue for improvement measures to reduce initial inpatient overuse of SUP and to prompt discontinuation before hospital discharge.

Keywords: Stress ulcers, Prophylaxis, Proton pump inhibitors, Histamine 2 receptor antagonists, Coagulopathy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0883-9441(09)00128-2

doi:10.1016/j.jcrc.2009.05.014

Journal of Critical Care
Volume 25, Issue 2 , Pages 214-220, June 2010